Kerala Ayurveda [KERALAYUR] vs Divi's Laboratories [DIVISLAB] Detailed Stock Comparison
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Kerala Ayurveda Ltd. wins in 5 metrics, Divi's Laboratories Ltd. wins in 13 metrics, with 0 ties. Divi's Laboratories Ltd. appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Kerala Ayurveda Ltd. | Divi's Laboratories Ltd. | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 617.16 | 67.11 | Divi's Laboratories Ltd. |
| Price-to-Book Ratio | 39.17 | 10.82 | Divi's Laboratories Ltd. |
| Debt-to-Equity Ratio | 938.32 | 0.58 | Divi's Laboratories Ltd. |
| PEG Ratio | 11.48 | 4.63 | Divi's Laboratories Ltd. |
| EV/EBITDA | -15.24 | 48.63 | Divi's Laboratories Ltd. |
| Profit Margin (TTM) | -18.52% | 24.04% | Divi's Laboratories Ltd. |
| Operating Margin (TTM) | -8.08% | 29.65% | Divi's Laboratories Ltd. |
| EBITDA Margin (TTM) | N/A | 29.65% | N/A |
| Return on Equity | 140.14% | 14.64% | Kerala Ayurveda Ltd. |
| Return on Assets (TTM) | -10.84% | 12.94% | Divi's Laboratories Ltd. |
| Free Cash Flow (TTM) | $-84.95M | $2.15B | Divi's Laboratories Ltd. |
| Dividend Yield | N/A | 0.91% | N/A |
| 1-Year Return | -53.05% | 0.83% | Divi's Laboratories Ltd. |
| Price-to-Sales Ratio (TTM) | 2.49 | 16.18 | Kerala Ayurveda Ltd. |
| Enterprise Value | $3.73B | $1,635.46B | Divi's Laboratories Ltd. |
| EV/Revenue Ratio | 2.93 | 15.86 | Kerala Ayurveda Ltd. |
| Gross Profit Margin (TTM) | 87.04% | 63.71% | Kerala Ayurveda Ltd. |
| Revenue per Share (TTM) | $105 | $388 | Divi's Laboratories Ltd. |
| Earnings per Share (Diluted) | $-19.60 | $93.66 | Divi's Laboratories Ltd. |
| Beta (Stock Volatility) | 0.08 | 0.19 | Kerala Ayurveda Ltd. |
Kerala Ayurveda Ltd. vs Divi's Laboratories Ltd. Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Kerala Ayurveda Ltd. | -2.98% | -14.09% | -15.84% | -20.57% | -50.84% | -46.37% |
| Divi's Laboratories Ltd. | 0.30% | -3.25% | -0.65% | 4.12% | 1.88% | 3.66% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Kerala Ayurveda Ltd. | -53.05% | 64.05% | 238.54% | 225.21% | 225.76% | 263.24% |
| Divi's Laboratories Ltd. | 0.83% | 89.86% | 56.44% | 484.44% | 1,625.50% | 9,907.51% |
Performance & Financial Health Analysis: Kerala Ayurveda Ltd. vs Divi's Laboratories Ltd.
| Metric | KERALAYUR | DIVISLAB |
|---|---|---|
| Market Information | ||
| Market Cap | ₹3.10B | ₹1.69T |
| Market Cap Category | Small cap | Large cap |
| 10 Day Avg. Volume | 11,583 | 253,443 |
| 90 Day Avg. Volume | 41,986 | 283,911 |
| Last Close | ₹169.55 | ₹6,596.50 |
| 52 Week Range | ₹150.00 - ₹625.00 | ₹5,636.50 - ₹7,071.50 |
| % from 52W High | -72.87% | -6.72% |
| All-Time High | ₹625.00 (Jul 01, 2025) | ₹7,071.50 (Jul 08, 2025) |
| % from All-Time High | -72.87% | -6.72% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.06% | 0.12% |
| Quarterly Earnings Growth | 0.06% | -0.01% |
| Financial Health | ||
| Profit Margin (TTM) | -0.19% | 0.24% |
| Operating Margin (TTM) | -0.08% | 0.30% |
| Return on Equity (TTM) | 1.40% | 0.15% |
| Debt to Equity (MRQ) | 938.32 | 0.58 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹6.23 | ₹580.95 |
| Cash per Share (MRQ) | ₹4.08 | ₹122.95 |
| Operating Cash Flow (TTM) | ₹43.75M | ₹19.67B |
| Levered Free Cash Flow (TTM) | ₹-139,590,000 | ₹21.91B |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | 0.91% |
| Last 12-Month Dividend | N/A | ₹60.00 |
Valuation & Enterprise Metrics Analysis: Kerala Ayurveda Ltd. vs Divi's Laboratories Ltd.
| Metric | KERALAYUR (Apr 24, 2026) | DIVISLAB (Apr 24, 2026) |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 617.16 | 67.11 |
| Forward P/E | N/A | 53.75 |
| PEG Ratio | 11.48 | 4.63 |
| Price to Sales (TTM) | 2.49 | 16.18 |
| Price to Book (MRQ) | 39.17 | 10.82 |
| Market Capitalization | ||
| Market Capitalization | ₹3.10B | ₹1.69T |
| Enterprise Value | ₹3.73B | ₹1.64T |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 2.93 | 15.86 |
| Enterprise to EBITDA | -15.24 | 48.63 |
| Risk & Other Metrics | ||
| Beta | 0.08 | 0.19 |
| Book Value per Share (MRQ) | ₹6.23 | ₹580.95 |
Financial Statements Comparison: Kerala Ayurveda Ltd. vs Divi's Laboratories Ltd.
Financial Metrics
Loading Financial Charts...
Revenue
Operating Margin
Profit Margin
Long Term Debt
Income Flow Analysis
Financial Statements Comparison
Income Statement
| Metric | KERALAYUR (2025) | DIVISLAB (2025) |
|---|---|---|
| Revenue/Sales | 1.19B | 93.25B |
| Cost of Goods Sold | 249.68M | 38.70B |
| COGS % of Revenue | 21.0% | 41.5% |
| Gross Profit | 942.01M | 54.55B |
| Gross Margin | 79.0% | 58.5% |
| Research & Development | 1.26M | 270.00M |
| Operating Income (EBIT) | -99.66M | 25.71B |
| Operating Margin | -8.4% | 27.6% |
| EBITDA | -42.40M | 33.19B |
| EBITDA Margin | -3.6% | 35.6% |
| Pre-Tax Income | -122.36M | 29.16B |
| Pre-Tax Income % of Revenue | -10.3% | 31.3% |
| Income Tax | 17.23M | 7.25B |
| Income Tax % of Revenue | 1.4% | 7.8% |
| Net Income (Profit) | -139.59M | 21.91B |
| Profit Margin | -11.7% | 23.5% |
Balance Sheet & Liquidity Metrics
| Metric | KERALAYUR (2025) | DIVISLAB (2025) |
|---|---|---|
| Cash & Equivalents | 33.89M | 4.15B |
| Total Current Assets | 407.67M | 100.81B |
| Total Current Assets % of Revenue | 34.2% | 108.1% |
| Total Current Liabilities | 879.75M | 14.52B |
| Total Current Liabilities % of Revenue | 73.8% | 15.6% |
| Long-Term Debt | 222.20M | 20.00M |
| Long-Term Debt % of Revenue | 18.6% | 0.0% |
| Total Shareholders Equity | -99.60M | 149.69B |
| Retained Earnings | N/A | 134.00B |
| Retained Earnings % of Revenue | 0.0% | 143.7% |
| Property, Plant & Equipment | 10.08M | 3.19B |
Cash Flow Statement Comparison
| Metric | KERALAYUR (2025) | DIVISLAB (2025) |
|---|---|---|
| Operating Cash Flow | 43.75M | 19.67B |
| Operating Cash Flow % of Revenue | 3.7% | 21.1% |
| Capital Expenditures | -133.20M | -14.38B |
| Free Cash Flow | -84.95M | 2.15B |
| FCF Margin | -7.1% | 2.3% |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | KERALAYUR | DIVISLAB |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Shares Outstanding | 13.00M | 265.47M |
| Float Shares | 6.30M | 117.72M |
| % Held by Insiders | 52.41% | 52.04% |
| % Held by Institutions | 0.00% | 28.65% |
| % Held by Public | 47.59% | 19.31% |
Dividend Analysis & Yield Comparison: Kerala Ayurveda Ltd. vs Divi's Laboratories Ltd.
| Metric | KERALAYUR | DIVISLAB |
|---|---|---|
| Last 12-Month Dividend | N/A | ₹60.00 |
| Last 12-Month Dividend Yield | N/A | 0.91% |
| 3-Year Avg Annual Dividend | N/A | ₹50.00 |
| 3-Year Avg Dividend Yield | N/A | 0.70% |
| 3-Year Total Dividends | N/A | ₹150.00 |
| Ex-Dividend Date | N/A | Jul 25, 2025 |